查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2000387

墨盒市场：市场规模、份额、成长和行业分析（按材料、尺寸和应用划分），区域预测至2034年

Cartridges Market, Size, Share, Growth, and Industry Analysis, By Material Type (Glass and Plastic), By Size (1ml to 5ml, 5ml to 15ml and 15ml to 30ml), By Application (Diabetes and Others), Regional Forecast to 2034
出版日期: | 出版商: Prismane Consulting | 英文 165 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球墨水匣市场

受慢性病和急性病治疗领域对预填充即用型给药系统需求不断增长的推动，全球药筒市场预计将在2025年至2034年间以7.1%的复合年增长率增长。药筒通常用于笔式註射器和自动注射器，在确保剂量精准、无菌和患者便利性方面发挥着至关重要的作用。随着糖尿病等慢性病盛行率的上升以及生物製药自我给药方式的普及，药筒正成为现代给药系统的重要组成部分。该市场的特点是材料工程、精密成型和製药级製造技术的进步，以满足严格的监管要求和不断发展的以患者为中心的医疗保健模式。

按材料类型分類的需求

从材料类型来看，市场区隔将注射剂筒分为玻璃和塑胶两大类。玻璃注射剂筒因其优异的耐化学性、卓越的阻隔性以及与多种注射药物的相容性而占据主导地位。特别是硼硅酸玻璃，因其稳定性高且萃取率低，成为胰岛素和生物製药的理想选择。然而，在需要轻量化设计、更高抗破损性和成本效益的应用领域，塑胶注射筒正日益受到关注。高性能环烯烃聚合物（COP）和环烯烃共聚物（COCs）的开发正在拓展塑胶注射剂筒在先进药物输送系统中的应用范围。随着製药公司在器械设计和患者便利性方面不断追求差异化，预计未来几年塑胶註射剂筒的应用将加速成长。

尺寸需求

从容量大小来看，胰岛素笔芯市场可分为1ml-5ml、5ml-15ml及15ml-30ml三个细分市场。其中，1ml-5ml细分市场占据较大份额，这主要归功于其在胰岛素笔和其他皮下注射疗法中的广泛应用。这些小巧的笔芯优化了给药的精准性，并提升了患者的便利性，使其非常适合用于糖尿病和其他慢性疾病的治疗。随着生物製药和需要中等剂量的特药的日益普及，5ml-15ml细分市场的发展势头强劲。同时，15ml-30ml细分市场预计将在特殊治疗以及特定的兽医和医院应用中拥有一定的市场需求。随着生物製药和联合治疗在药物研发管线中占据越来越重要的地位，预计各种容量的胰岛素笔芯需求将保持强劲。

申请需求

从应用领域来看，糖尿病在全球胰岛素笔芯市场占最大份额。糖尿病在全球日益加重，尤其是在新兴经济体，这推动了对胰岛素输注系统的需求，包括可重复使用和一次性胰岛素笔。与传统的管瓶和注射器相比，基于笔芯的胰岛素笔系统具有便利性、精确性和患者依从性高等优点，使其成为更受欢迎的选择。 「其他」领域，包括荷尔蒙疗法、生育治疗和生物製药，也在快速成长。随着许多注射药物转向自我给药形式，胰岛素笔芯有望在註射药物生态系统中占据更大的份额。

市场驱动因素

全球胰岛素笔芯市场的主要驱动因素是全球糖尿病患者数量的不断增长以及胰岛素笔式给药系统日益普及。随着医疗保健系统越来越重视居家照护和提高病患的用药依从性，整合式胰岛素笔芯在安全性、准确性和便利性方面展现出极具吸引力的提案。

市场限制因素

一个主要的限制因素是与药品包装组件相关的严格法规和品质合规要求。生产药筒需要对无尘室设施、先进的检测系统和验证流程进行大量资本投入，这可能会限制市场准入，并给中小型製造商带来价格压力。

区域需求

北美仍然是主要市场，这得益于其高糖尿病盛行率、先进的医疗保健基础设施以及自行注射装置的广泛应用。大型製药企业的存在和严格的监管标准进一步推动了对高品质、合规的注射剂盒系统的需求。欧洲紧随其后，其强劲的需求得益于成熟的製药製造地以及对病患​​安全和器械创新的高度重视。德国和瑞士等国是玻璃和特殊包装产品的主要生产中心。

亚太地区正崛起为成长最快的地区，这主要得益于糖尿病患者数量的快速成长、医疗保健服务的改善以及药品生产能力的提升。中国和印度等国正在加大对注射剂生产的投资，从而推高了对玻璃和塑胶注射笔芯的需求。此外，具有成本竞争力的生产能力和不断扩大的出口活动也巩固了该地区在全球供应链中的地位。

主要製造商

市场上的主要企业包括 Stevanato 集团、Nipro 公司、Gerreshimer AG、West Pharmaceutical Services Inc.、Schott AG、Transcoject GmbH、山东医用玻璃有限公司、Datwlyer Holding Inc.、Aptar Group Inc. 和 Sonata Rubber。

总体而言，受材料创新、慢性病患病率上升以及注射药物输送方式向以患者为中心的解决方案不断转变的推动，全球注射剂市场预计将稳步扩张。

目录

第一章：引言

第二章 市场概览

  • 市场演变
  • 需求概览
  • 产业结构
  • 战略挑战
  • 终端用户趋势
  • 成长预测

第三章：经济与能源展望

  • 国内生产毛额和人口统计数据
  • 货币/财政政策

第四章：墨盒概述和市场概览

  • 产品描述
  • 等级和特性
  • 原料
  • 製造过程
  • 环境问题
  • 价值链
  • 目的

第五章 市场动态与产业趋势

  • 市场动态
    • 促进因素
    • 抑制因子
    • 机会
    • 任务

第六章：全球墨盒需求分析（按材料类型、尺寸和应用划分）（价值）（2018-2034 年）

  • 战略挑战及新冠疫情的影响
  • 需求分析与预测（2018-2034）
    • 要求
    • 需求成长率（%）
    • 推进分析
    • 其他功能性成分
  • 全球墨水匣市场（按材料类型划分）
    • 玻璃
    • 塑胶
  • 全球墨水匣市场（按尺寸）
    • 1ml～5ml
    • 5ml～15ml
    • 15ml～30ml
  • 全球墨水匣市场（按应用领域划分）
    • 糖尿病
    • 其他的

第七章 需求分析与市场概览（按地区和国家）（价值）（2018-2034 年）

  • 战略挑战及新冠疫情的影响
  • 需求分析与预测（2018-2034）
  • 需求成长率（%）
  • 墨水匣市场（依材质类型划分）
  • 墨水匣市场（依尺寸）
  • 墨水匣市场（按应用领域划分）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 西欧
    • 德国
    • 法国
    • 义大利
    • 英国
    • 西班牙
    • 其他的
  • 中欧/东欧
    • 俄罗斯
    • 波兰
    • 土耳其
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • ASEAN
    • 其他的
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 中东
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 非洲
    • 南非
    • 其他的

第八章：价格分析

第九章：关键策略挑战与商业机会评估

  • 市场吸引力评估
  • 未来前景及目标市场研究

第十章：战略建议与提案

第十一章：公司分析与市占率分析

  • 墨盒製造商公司简介/公司分析
    • 基本资料
    • 总部、主要市场
    • 拥有
    • 公司财务
    • 製造地
    • 全球销售
    • 员工总数
    • 产品系列/服务/解决方案
    • Prismane Consulting 的关键商务策略及概况
    • 近期趋势
    • 目标公司

第十二章註：本部分包含企业资料、财务报表、製造地和营运区域。财务报表仅收录于已向美国证券交易委员会 (SEC) 提交的文件、年度报告或公司网站上公布的公司。本报告中所包含的所有财务报表均以美元计价。以其他货币计价的财务报表已使用平均外汇换算。公司简介可能包含製造商、供应商和经销商。

第十三章附录

简介目录

Global Cartridges Market

The global cartridges market is expected to witness a CAGR of 7.1% between 2025-2034, driven by the rising demand for prefillable and ready-to-use drug delivery systems across chronic and acute therapeutic segments. Cartridges, typically used in pen injectors and autoinjectors, play a critical role in ensuring accurate dosing, sterility, and patient convenience. With the increasing prevalence of chronic diseases such as diabetes and the shift toward self-administration of biology, cartridges have emerged as an integral component of modern drug delivery. The market is characterized by advancements in material engineering, precision molding, and pharmaceutical-grade manufacturing, aligning with stringent regulatory requirements and evolving patient-centric healthcare models.

Demand by Material Type

By material type, the market is segmented into glass and plastic cartridges. Glass cartridges continue to dominate due to their superior chemical resistance, excellent barrier properties, and compatibility with a wide range of injectable drugs. Borosilicate glass, in particular, is preferred for insulin and biologic formulations owing to its stability and low extractables profile. However, plastic cartridges are gaining traction, especially in applications requiring lightweight design, enhanced break resistance, and cost efficiency. The development of high-performance cyclic olefin polymers (COP) and cyclic olefin copolymers (COC) is expanding the scope of plastic cartridges in advanced drug delivery systems. As pharmaceutical companies seek differentiation in device design and patient usability, plastic cartridges are expected to witness accelerated adoption in the coming years.

Demand by Size

Based on size, the cartridges market is categorized into 1ml to 5ml, 5ml to 15ml, and 15ml to 30ml. The 1ml to 5ml segment holds a significant share, primarily due to its widespread use in insulin pens and other subcutaneous injectable therapies. These compact cartridges are optimized for precise dosing and patient convenience, making them highly suitable for diabetes management and other chronic conditions. The 5ml to 15ml segment is gaining momentum with the growing use of biologics and specialty pharmaceuticals that require moderate-volume delivery. Meanwhile, the 15ml to 30ml segment is finding niche applications in specialized therapies and certain veterinary or hospital-based uses. As drug pipelines increasingly feature biologics and combination therapies, demand across varied cartridge sizes is expected to remain robust.

Demand by Application

In terms of application, diabetes represents the dominant segment in the global cartridges market. The rising global burden of diabetes, particularly in emerging economies, is fueling the demand for insulin delivery systems, including reusable and disposable pen injectors. The convenience, accuracy, and patient compliance associated with cartridge-based pen systems have made them a preferred choice over traditional vial-and-syringe methods. The "others" segment, encompassing hormonal therapies, fertility treatments, and biologic drugs, is also expanding rapidly. As more injectable drugs transition to self-administration formats, cartridges are poised to capture a larger share of the injectable drug delivery ecosystem.

Market Driver

A key driver of the global cartridges market is the rising prevalence of diabetes worldwide, coupled with the growing adoption of pen-based insulin delivery systems. As healthcare systems emphasize home-based care and improved patient adherence, cartridge-integrated injectors offer a compelling value proposition in terms of safety, accuracy, and convenience.

Market Restraint

One significant restraint is the stringent regulatory and quality compliance requirements associated with pharmaceutical packaging components. Manufacturing cartridges demands high capital investment in cleanroom facilities, advanced inspection systems, and validation processes, which can limit market entry and exert pricing pressure on smaller manufacturers.

Demand by Region

North America remains a leading market, supported by high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of self-injection devices. The presence of major pharmaceutical companies and stringent regulatory standards further drives demand for high-quality, compliant cartridge systems. Europe follows closely, with robust demand stemming from established pharmaceutical manufacturing hubs and strong emphasis on patient safety and device innovation. Countries such as Germany and Switzerland serve as key centers for glass and specialty packaging production.

Asia-Pacific is emerging as the fastest-growing region, propelled by a rapidly expanding diabetic population, increasing healthcare access, and rising pharmaceutical manufacturing capabilities. Countries such as China and India are witnessing growing investments in injectable drug production, boosting demand for both glass and plastic cartridges. Additionally, cost-competitive manufacturing and expanding export activities are strengthening the region's position in the global supply chain.

Key Manufacturers

The major players operating in the market include Stevanato group, Nipro corporation, Gerreshimer AG, West Pharmaceutical services Inc., Schott AG, Transcoject GmbH, Shandong Medicinal Glass Co ltd, Datwlyer Holding Inc, Aptar Group Inc, Sonata Rubber

Overall, the global cartridges market is positioned for steady expansion, supported by innovation in materials, rising chronic disease prevalence, and the ongoing transformation of injectable drug delivery toward patient-centric solutions.

Table of Contents

1. Introduction

  • 1.1. Scope
  • 1.2. Market Coverage
    • 1.2.1. Material Type
    • 1.2.2. Size
    • 1.2.3. Applications
    • 1.2.4. Regions
    • 1.2.5. Countries
  • 1.3. Years Considered
    • 1.3.1. Historical - 2018 - 2023
    • 1.3.2. Base - 2024
    • 1.3.3. Forecast Period - 2025 - 2034
  • 1.4. Research Methodology
    • 1.4.1. Approach
    • 1.4.2. Research Methodology
    • 1.4.3. Prismane Consulting Market Models
    • 1.4.4. Assumptions & Limitations
    • 1.4.5. Abbreviations & Definitions
    • 1.4.6. Conversion Factors
    • 1.4.7. Data Sources

2. Market Synopsis

  • 2.1. Market Evolution
  • 2.2. Demand Overview
  • 2.3. Industry Structure
  • 2.4. Strategic Issues
  • 2.5. End-use Trends
  • 2.6. Growth Forecast

3. Economic & Energy Outlook

  • 3.1. GDP and Demographics
  • 3.2. Monetary & Fiscal Policies

4. Introduction to Cartridges and Market Overview

  • 4.1. Product Description
  • 4.2. Grades & Properties
  • 4.3. Raw Material
  • 4.4. Manufacturing Process
  • 4.5. Environmental Issues
  • 4.6. Value Chain
  • 4.7. Applications

5. Market Dynamics and Industry Trends

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
    • 5.1.4. Challenges

6. Global Cartridges Demand Analysis, By Material Type, By Size and By Application (Value) (2018-2034)

  • 6.1. Strategic Issues and COVID-19 Impact
  • 6.2. Demand Analysis and Forecast (2018 - 2034)
    • 6.2.1. Demand
    • 6.2.2. Demand Growth Rate (%)
    • 6.2.3. Driving Force Analysis
    • 6.2.4. Other Functional Ingredients
  • 6.3. Global Cartridges Market, By Material Type
    • 6.3.1. Glass
    • 6.3.2. Plastic
  • 6.4. Global Cartridges Market, By Size
    • 6.4.1. 1ml to 5ml
    • 6.4.2. 5ml to 15ml
    • 6.4.3. 15ml to 30ml
  • 6.5. Global Cartridges Market, By Application
    • 6.5.1. Diabetes
    • 6.5.2. Others

7. Demand Analysis and Market Review, By Region, By Country (Value), (2018- 2034)

  • 7.1. Strategic Issues and COVID-19 Impact
  • 7.2. Demand Analysis and Forecast (2018-2034)
  • 7.3. Demand Growth Rate (%)
  • 7.4. Cartridges Market, By Material Type
  • 7.5. Cartridges Market, By Size
  • 7.6. Cartridges Market, By Application
  • 7.7. North America
    • 7.7.1. USA
    • 7.7.2. Canada
    • 7.7.3. Mexico
  • 7.8. Western Europe
    • 7.8.1. Germany
    • 7.8.2. France
    • 7.8.3. Italy
    • 7.8.4. United Kingdom
    • 7.8.5. Spain
    • 7.8.6. Rest of Western Europe
  • 7.9. Central & Eastern Europe
    • 7.9.1. Russia
    • 7.9.2. Poland
    • 7.9.3. Turkey
    • 7.9.4. Rest of Central & Eastern Europe
  • 7.10. Asia-Pacific
    • 7.10.1. China
    • 7.10.2. Japan
    • 7.10.3. India
    • 7.10.4. South Korea
    • 7.10.5. ASEAN
    • 7.10.6. Rest of Asia-Pacific
  • 7.11. Central & South America
    • 7.11.1. Brazil
    • 7.11.2. Argentina
    • 7.11.3. Rest of Central & South America
  • 7.12. Middle East
    • 7.12.1. Saudi Arabia
    • 7.12.2. UAE
    • 7.12.3. Rest of Middle East
  • 7.13. Africa
    • 7.13.1. South Africa
    • 7.13.2. Rest of MEA

8. Pricing Analysis

9. Key Strategic Issues and Business Opportunity Assessment

  • 9.1. Market Attractiveness Assessment
  • 9.2. Prospective & Target Market Study

10. Strategic Recommendation & Suggestions

11. Company Analysis and Market Share Analysis

  • 11.1. Cartridges Manufacturers Profiles/ Company Analysis
    • 11.1.1. Basic Details
    • 11.1.2. Headquarter, Key Markets
    • 11.1.3. Ownership
    • 11.1.4. Company Financial
    • 11.1.5. Manufacturing Bases
    • 11.1.6. Global Turnover
    • 11.1.7. Total Employee
    • 11.1.8. Product Portfolio / Services / Solutions
    • 11.1.9. Key Business Strategies adopted and Prismane Consulting Overview
    • 11.1.10. Recent Developments
    • 11.1.11. Companies Covered
      • 11.1.11.1. Stevanato Group
      • 11.1.11.2. Nipro Corporation
      • 11.1.11.3. Gerreshimer AG
      • 11.1.11.4. West Pharmaceuticals Services Inc
      • 11.1.11.5. Schott AG
      • 11.1.11.6. Transcoject GmbH
      • 11.1.11.7. Shandong Medical Glass Co ltd
      • 11.1.11.8. Datwlyer Holding Inc
      • 11.1.11.9. Aptar Group Inc
      • 11.1.11.10. Sonata Rubber
      • 11.1.11.11. Other Manufacturers

12. Note: This section includes company information, company financials, manufacturing bases, and operating regions. Company financials have been mentioned only for those companies where financials were available in SEC Filings, annual reports, or company websites. All the reported financials in this report are in U.S. Dollars. Financials reported in other currencies have been converted using average currency conversion rates. Company profiles may include manufacturers, suppliers, and distributors.

13. Appendices

  • 13.1. Demand- Regions
  • 13.2. Demand- Countries